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Background: Plasmodium vivax re-emerged in 1993 and has now become a major public health problem during
the summer season in South Korea. The aim of this study was to interpret and understand the meaning of
seroepidemiological studies for developing the best malaria control programme in South Korea.
Methods: Blood samples were collected in Gimpo city, Paju city, Yeoncheon County, Cheorwon County and
Goseong County of high risk area in South Korea. Microscopy was performed to identify patients infected with P.
vivax. Antibody detection for P. vivax was performed using indirect fluorescent antibody test (IFAT).
Results: A total of 1,574 blood samples was collected from participants in the study areas and evaluated against
three parameters: IFAT positive rate, annual antibody positive index (AAPI), and annual parasite index (API). The IFAT
positive rate was 7.24% (n = 114). Of the five study areas, Gimpo had the highest IFAT positive rate (13.68%) and
AAPI (4.63). Yeongcheon had the highest API in 2005 (2.06) while Gimpo had the highest API in 2006 (5.00). No
correlation was observed between any of the three parameters and study sites' distance from the demilitarized
zone (DMZ).
Conclusions: These results showed that P. vivax antibody levels could provide useful information about the
prevalence of malaria in endemic areas. Furthermore, AAPI results for each year showed a closer relationship to API
the following year than the API of the same year and thus could be helpful in predicting malaria transmission risks.Background
Plasmodium vivax is the causative agent of relapsing
benign tertian human malaria and is the second-most
important human malaria that annually afflicts several
hundred million people. The disease is a major public
health problem and has socio-economic ramifications
for many temperate and tropical countries [1]. While
vivax malaria has been reported throughout the Korean
peninsula for several centuries, it was not until 1913 that
the first scientific document was published. At that time,
malaria occurred throughout the country without
recognizable geographical differences [2]. The incidence
of vivax malaria decreased rapidly as a result of eco-
nomic improvement following the Korean War, a* Correspondence: tongsookim@inha.ac.kr; rainlee67@yahoo.co.kr
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reproduction in any medium, provided the ornational malaria eradication programme, and assistance
from the World Health Organization (WHO) [3,4]. As
the last two sporadic cases detected in the 1980s were
believed to be the result of latent malaria parasites trans-
mitted the previous year [5], vivax malaria was reported
to have been eradicated in South Korea by the late 1970s
[6]. In 1993, a South Korean army soldier serving in
northern Gyeonggi Province, with no travel history, was
diagnosed with vivax malaria [7]. Subsequently, Cho
et al. reported two civilian patients infected with vivax
malaria [8]. By 2005, a total of 21,419 indigenous vivax
malaria cases had been confirmed in South Korea, and a
total of at least 937,634 vivax malaria cases had been
reported from the entire Korean peninsula, both South
and North Korea. The number of vivax malaria cases
peaked in South Korea in 2000 with 8.9 cases/100,000,
followed by a sharp decline of approximately 26-40% per
annum to 1.8 and 2.9 cases/100,000 in 2004 and 2005,
respectively [9]. The highest malaria cases centred
around Paju, Yeoncheon, Cheorwon, Gimpo, Ganghwa,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(DMZ) separating North and South Korea. Following
the re-emergence of malaria, subsequent high indigen-
ous transmission rates and population movement caused
great concern because of the increased geographical ex-
pansion potential [10].
Serological data obtained by an indirect fluorescent
antibody test (IFAT) may provide useful for levels of
malaria endemicity, as well as the time period of infec-
tion [11]. Of blood samples from 845 participants, who
were residents of Gimpo from November to December
1998, 24 were positive for malaria antibodies by IFAT.
Four seropositive participants (16.7%) developed malaria
the following year. In 1999, 125 of 5,797 participants
from the same area were seropositive by IFAT of which
12.8% (16/125) were positive for malaria parasites by
polymerase chain reaction (PCR). Serological surveys
have provided valuable epidemiological information, es-
pecially in areas with low level of endemicity [12,13].
The rate of parasitaemia is the classical method for
measuring the endemicity of malaria, however, the inci-
dence of parasitaemia alone fails to provide an adequate
description of the occurrence of malaria in a population.
Therefore, the incidence of malaria is low, the applica-
tion of IFAT could be used to more accurately reflect the
malaria situation in a particular area [14,15].
In this study, antibody-positive rates using IFAT were
obtained from malaria high-risk areas near the DMZ
and the results compared with the malaria prevalence in
those areas during the year of the survey and the follow-
ing year.
Methods
Study areas and blood sample collection
The study sites were within 20 km of the DMZ and are
shown in Figure 1. The study was conducted in Gimpo
(Figure 1A), Paju (Figure 1B), and Yeoncheon (Figure 1C)
of Gyeonggi Province, and Cheorwon (Figure 1D) and
Goseong (Figure 1E) of Gangwon Province, South Korea,
from late October to mid-December 2005. Blood samples
were collected from participants residing in 35 villages in
three cities located in Gyeonggi Province, and nine villages
in two cities in Gangwon Province. A total of 1,574 blood
samples (1.43%) were collected from 110,424 inhabitants
of the study areas in 2005. All participants were volunteers
enrolled by providing verbal informed consent. Blood
samples were collected randomly from volunteers and
ruled out those who had previously been infected with
malaria. Three ml of blood was collected from each indi-
vidual and thin and thick blood smears prepared for
microscopic examination (magnification 7 x 100). The
blood samples were transferred to the Korean National In-
stitute of Health (KNIH), Korea Centers for Disease Con-
trol and Prevention (KCDC), where blood and sera wereseparated and stored at −20°C for future antibody analysis.
The study protocol was reviewed and approved by the
KNIH Human Ethics Committee.
Indirect fluorescent antibody test
To test for antibodies against malaria, IFAT was per-
formed with the whole blood infected with P. vivax [16-
18]. Briefly, malaria parasite infected blood was collected
from patients. Plasma and white blood cells were
removed and red blood cells suspended in phosphate
buffered saline (PBS, pH 7.2). Samples were centrifuged
for 5 min at 2,500 rpm. The supernatant was discarded
and the cells were resuspended in fresh PBS. This wash
step was repeated three more times, and then an appro-
priate amount of PBS was added. Red blood cells were
mounted in each well of Teflon-coated slides, dried for
12 hr at room temperature, and then stored at −70°C.
To determine the antibody titres against P. vivax of each
individual, the antigen slides were fixed in pre-cooled
acetone (−20°C) for 10 min, washed with PBS, and then
20 μl of diluted sera, 1:32 to 1:8,192 (vol/vol), was added
to each well. Positive and negative controls were also
spotted onto each slide, and the slides were incubated in
a humidified chamber for 30 min at 37°C. The reactions
were quenched by washing the reacted sera with PBS for
6 min, and then the samples were dried at room
temperature. Diluted FITC conjugated anti-human IgG
(Sigma, 1:32 vol/vol in PBS) was added to each well and
incubated and washed as described above. Several drops
of buffered glycerol were added to the samples, cover-
slips applied and then examined under a fluorescence
microscope at 400x.
Calculation of annual parasite index (API)
API was calculated as the number of malaria-positive
patients per 1,000 inhabitants at each of the study sites,
API = (number of positive slides/total number of slides) ×
1000 [19].
Calculation of annual antibody positive index (AAPI)
AAPI was calculated as the number of malaria antibody
positive participants per 1,000 inhabitants for each of
the study sites, AAPI = (number of antibody positive
slides/total number of slides) × 1000.
Data analysis
The antibody-positive individuals who had been patients
in previous years were excluded during data analysis. The
relationship of distance from the DMZ as related to IFAT
positive rate, API and AAPI were analysed by Pearson’s
chi-squared test. The relationship between AAPI, API,
and IFAT positive rate for each village was analysed by
two-way ANOVA. Data analyses were performed using


























































Figure 1 Study areas. (A) Gimpo; (B) Paju; (C) Yeoncheon; (D) Cheorwon; (E) Goseong. a, Wolgot village; b, Tongjin village; c, Haseong village;
d, Gunnae village; e, Munsan village; f, Tanhyun village; g, Yeoncheon village; h, Cheongsan village; i, Dongsong village; j, Galmal village; k,
Gimhwa village; l, Seo village; m, Geunnam village; n, Hyeonnae village.
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IFAT positive rate
The criteria for a positive IFAT result were established in
a previous experiment. Briefly, when 86 individuals and 58
vivax malaria patients were tested, normal individuals had
a serum dilution under 1:16 (range from 0 to 1:16), and
the 58 vivax malaria patients had a serum dilution over
1:256 (range from 1:256 to 1:4,096). Therefore, a positive
antibody response was defined against vivax malaria as a
serum dilution above (≥)1:32. The specificity of IFAT was
100% and sensitivity was 97% [20]. A total of 114 samples
from 1,574 participants (7.24%) that were identified as
negative by microscopic examination were positive by
IFAT. A total 17 positive samples exhibited IFAT scores of
≥1:256, which was the criterion used to identify malaria
patients. Gimpo had the highest positive rate at 13.68%
(52/380) followed by Cheorwon (7.01%, 27/385), Paju
(5.51%, 26/472), Yeoncheon (3.32%, 7/211), and Goseong
(1.59%, 2/126) (Additional file 1). Tongjin village, located
in the upper-middle area of Gimpo, had the highest posi-
tive rate at 17.65% (9/51) followed by Wolgot village
(14.63%, 24/164) in the north-west part of the city, and
Haseong village (11.52%, 19/165) in the north-east
(Additional file 2, Figure 1A). Gunnae village, located
adjacent to the DMZ in Paju, had the highest positive rateof 8.89% (8/90) followed by Munsan village (7.26%, 13/179)
in the upper-middle of the city, and Tanhyun village
(2.46%, 5/203) in the north-west (Additional file 3,
Figure 1B). Cheongsan village, located far south of Yeonch-
eon, had the highest positive rate at 5.41% (2/37) followed
by Yeoncheon village (2.87%, 5/174) located in the middle
of Yeoncheon (Additional file 4, Figure 1C). Galmal village,
located in the south-west of Cheorwon, had the highest
positive rate at 11.48% (7/61) followed by Seo village
(9.52%, 4/42) in the south-east of the city, Geunnam village
(9.09%, 5/55) and Gimhwa village (6.67%, 2/30) in the
north-east, and Dongsong village (4.57%, 9/197) in the west
of the city (Additional file 5, Figure 1D). Hyeonnae village,
located in the north part of Goseong, had a positive rate of
1.59% (2/126) (Additional file 6, Figure 1E).
Comparison of the annual antibody positive index (AAPI)
The AAPI method was designed to normalize the IFAT
positive rates. Total AAPI was 1.03 for study sites within
Gimpo showing the highest AAPI (4.63) followed by Paju
(0.64), Cheorwon (0.62), Yeoncheon (0.60), and Goseong
(0.57) (Additional file 1). Wolgot village showed the highest
AAPI in Gimpo (12.04) followed by Haseong village (7.30),
and Tongjin village (1.36) (Additional file 2, Figure 1A).
Gunnae village had the highest AAPI in Paju (11.68)
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(0.42) (Additional file 3, Figure 1B). Yeoncheon village
(0.71) showed a higher AAPI than Cheongsan village (0.43)
in Yeoncheon (Additional file 4, Figure 1C). Geunnam vil-
lage showed the highest AAPI in Cheorwon (1.90) followed
by Gimhwa village (0.58), Seo village (0.58), Dongsong vil-
lage (0.54), and Galmal village (0.51) (Additional file 5,
Figure 1D). The AAPI of Hyeonnae village in Goseong was
0.57 (Additional file 6, Figure 1E).
Comparison of annual parasite index (API) results from
2005 and 2006
Total API for 2005 was 1.24 and 1.89 in 2006. The high-
est API was detected in Yeoncheon (2.06) followed by
Cheorwon (1.45), Gimpo (1.07), and Paju (0.94). There
were no malaria patients in Goseong in 2005. The high-
est API was detected in Gimpo (5.00) followed by Paju
(1.80), Cheorwon (1.45), Yeoncheon (1.03), and Goseong
(0.70). The AAPI results from 2005 indicated a closer re-
lationship to the API of 2006 (P= 0.0003) than to the
API of 2005 (P= 0.7436) (Additional file 1).
In 2005, the highest API in Gimpo was observed in
Wolgot village (2.01), followed by Tongjin village (1.21)
and Haseong village (0.00). In 2006, Wolgot village
showed the highest API followed by Haseong village
(6.54) and Tongjin village (2.41) (Figure 1A).
Similarly, a closer relationship was observed between
the AAPI of 2005 and the API of 2006 (P= 0.0097) than
between the AAPI of 2005 and the API of 2005
(P= 0.4388) (Additional file 2). In 2005, the highest API
in Munsan village was detected in Paju (1.14) followed
by Tanhyun village (0.51) and Gunnae village (0.00). In
2006, the highest API was in Gunnae village (5.84) fol-
lowed by Munsan village (1.82) and Tanhyun village
(1.52) (Additional file 3, Figure 1B). In Yeoncheon,
Yeoncheon village (2005; 3.41, 2006; 1.14) maintained a
higher positive API than Cheongsan village (2005: 0.00;
2006: 0.87). Here, the 2005 AAPI showed a closer rela-
tionship to the API of 2006 (P= 0.0116) than the API of
2005 (P= 0.4478) (Additional file 4, Figure 1C). For
Cheorwon in 2005, the highest API was detected in
Gimhwa village (2.33) followed by Geunnam village
(1.90), Dongsong village (1.66), Galmal village (1.54),
and Seo village (0.14). In 2006, Gimhwa village had the
highest API (2.63) followed by Geunnam village (1.90),
Dongsong village (1.37), Seo village (1.30), and Galmal
village (1.25) (Additional file 5, Figure 1D). The API in
Hyeonnae village in Goseong increased from 2005 (0.00)
to 2006 (0.70) (Additional file 6, Figure 1E).
Comparison between each parameter and distance from
the DMZ
Vivax malaria in South Korea is characterized as border
malaria [10,21]. It was tried to confirm this hypothesis byinvestigating whether the distance from the DMZ to each
study sites influenced the IFAT positive rate, AAPI, or API
in 2005 and 2006. In 2005, in the study areas of Gimpo,
the positive rates for IFAT (r2 = 0.9607, P=0.1271) and
API (r2 = 0.1897, P=0.7131) increased with distance from
DMZ, and in 2006, AAPI (r2 = 0.4931, P=0.5044) and API
(r2 = 0.9411, P= 0.1560) decreased with distance. However,
none of the parameters was significant (P> 0.05). In 2006,
the study areas of Paju, the positive rates for for IFAT
(r2 = 0.0497, P=0.8569), AAPI (r2 = 0.7473, P=0.3353)
and API (r2 = 0.6943, P=0.3729) decreased with distance
from the DMZ. Only 2005 results showed significant in-
crease of API with proximity to the DMZ (r2 = 0.9963,
P=0.0386) (P< 0.05). AAPI and API (2005 and 2006)
decreased with distance from the DMZ in the study areas
of Yeoncheon. Only the IFAT positive rate increased with
proximity to the DMZ. 2005 AAPI (r2 = 0.4539,
P=0.2124), 2005 API (r2 = 0.4068, P=0.2469), and the
2006 API rates (r2 = 0.5556, P=0.1482) decreased with dis-
tance from the DMZ in the study areas of Cheorwon.
Only positive rates of IFAT (r2 = 0.2542, P=0.3864)
increased, but the data were not significance (P> 0.05).
Discussion
The highest prevalence of malaria in South Korea was
observed for Paju and Yeoncheon, in Gyeonggi Province,
both of which are located within 10–15 km of the
southern border of the DMZ [10,21]. Therefore, it was
tried to determine the malaria transmission pattern in
the malaria-prevalent areas: Gimpo, Paju, Yeoncheon,
Cheorwon, and Goseong.
Based on the data, Tongjin village in Gimpo may be
dominated by locally transmitted malaria, because, in
2005, the IFAT positive (17.65%) and API (1.21) indices
for that village were much higher than those for Wolgot
village (5.70 km) and Haseong village (5.00 km), which
are closer to the DMZ (8.00 km). However, Wolgot vil-
lage had relatively high values for all three parameters
and was closest to the DMZ, suggesting that the malaria
transmission increased near the border. One of the main
rice fields is located in Gimpo, South Korea where there
are many places for Anopheles to breed, which suggests
the main reason for the high malaria prevalence
(Additional file 2). Gunnae village of Paju showed a
higher IFAT positive rate and higher AAPI than
Musan village or Tanhyun village, but there were no
malaria patients reported in 2005 (API= 0.00). However,
the API was 5.84 in 2006. This suggests that antibody-
positive rates might be useful for predicting the malaria
transmission in subsequent years. A new approach to
interpreting AAPI results would be helpful to more accur-
ately estimate community immunity in order to predict
malaria transmission in epidemic areas (Additional file 3).
In 2005, the AAPI (0.71) and API (3.41) of Yeoncheon
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did Cheongsan village in Yeoncheon, suggesting that
Yeoncheon may have been directly affected by mosquitoes
along the border with North Korea (Additional file 4).
Similarly, the AAPI and API of villages in Cheorwon
decreased as distance increased from the DMZ. Geunnam
village, located close to the DMZ, showed the highest
value of AAPI (1.90) and second highest API (2005: 1.90;
2006: 1.90) among the villages surveyed in Cheorwon. In
2005, AAPI for the other areas was between 0.51 and 0.58,
but the positive rate observed in Galmal village, located
far from the DMZ (18.18 km), exhibited the highest posi-
tive rate (11.48%) and an average value of API (2005: 1.54;
2006: 1.25). Thus, Galmal village exhibited the characteris-
tics of local malaria transmission. Gimhwa village exhib-
ited the highest values for API (2005: 2.33; 2006: 2.63) and
second-highest value for AAPI, and is located close to the
DMZ (Additional file 5). When it was considered the rela-
tionship between AAPI and API, AAPI results showed
significantly greater correlation with API in 2006
(P=0.0003) than in 2005 (P= 0.7436). From this, it was
concluded that the AAPI results on any given year may in-
dicate the malaria transmission pattern for the following
year. Because it would be helpful to be able to predict the
malaria transmission in following years, this hypothesis
should be tested for the purpose of developing diagnostic
tools to aid in eradicating malaria in Korea. AAPI results
may correlate with the long incubation period of malaria
in patients, when it is taken into consideration the time of
blood collection, as adult mosquitoes are not present or in
hibernation during the cold winter season. In humans, the
malaria parasites are dormant in the liver as hypnozoites,
with development usually initiated during the following
mosquito season. Going forward, it must be determined
the AAPI before malaria transmission occurs to determine
precisely what this index offers.
IFAT was applied in this study because serological data
provide useful evidence regarding the extent and degree
of malaria endemicity, and reflect the period of infection
[11], particularly in areas with low endemicity [13]. Add-
itionally, sensitivity and specificity of IFAT analysis are
much higher than enzyme linked immunosorbent assay
(ELISA) of merozoite surface protein-1 (MSP-1) and cir-
cumsporozoite surface protein (CSP) in previous data
[20]. The parasitaemia rate is the classical method for
measuring malaria endemicity, but incidence of parasit-
aemia alone cannot provide a complete and adequate
description of malaria infections among affected popula-
tions. When the incidence of malaria is low, mass blood
surveys based on microscopic examination do not yield
results commensurate with the work involved [14].
Therefore, the application of IFAT could be utilized to
more accurately reflect the malaria situation in a given
population [15].If non-latent cases are observed in early June, sporo-
zoites infection from mosquitoes to humans would have
occurred in mid-May of the same year. During April,
mosquitoes are usually infected with gametocytes by
blood meal from latent patients and would have to have
developed sporozoites in the salivary gland by mid-May
to be infective to human beings. Malaria cases observed
in May are largely due to latent malaria cases from the
previous year [22].
The most abundant anopheline mosquitoes captured
in the high-risk areas for malaria near the DMZ in
northern Gyeonggi province were Anopheles sinensis
(63.3%), Anopheles kleini (24.7%), and Anopheles pullus
(8.7%) [23]. The incidence of malaria peaks in August
after the rainy season and declines to baseline by mid-
October. Blood collections were conducted between late
October and mid-December when the active adult
anopheline population has disappeared. It was con-
ducted the same experimental design from 1996 to 1998,
during the early stage of re-emergence of vivax malaria
in South Korea, and the IFAT-determined antibody-posi-
tive rates in the study areas of Paju, Yeoncheon, and
Cheorwon were highly influenced by the proximity to
the DMZ. As some of the study areas far from the DMZ
showed high positive rates for IFAT, AAPI, and API in
2005 and 2006, it appears that the pattern of vivax mal-
aria transmission has changed and is no longer solely
affected by border conditions. In other words, the causa-
tive source of malaria transmission is now located inside
South Korea.
Conclusions
An interesting finding of this study was that antibody
detection using IFAT may provide useful information
regarding malaria prevalence in certain areas and indivi-
duals. These data may assist in identifying the areas at
increased risk, and which require a more or less inten-
sive surveillance the following years. Additionally, anti-
body detection helps to find asymptomatic patients who
play an important role in malaria transmission.
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